Table 2.
Screening finding regarding the RMRC and occurrence of CVD and CVD death.
| Transitions | Subject/screens | % |
|---|---|---|
| At prevalence screening | ||
| Free of metabolic disorder (FMD) | 16,886 | 35.55 |
| Mild metabolic disorder (MMD) | 22,480 | 47.33 |
| Metabolic syndrome (MetS) | 8129 | 17.12 |
| In the subsequent screening | ||
| From FMD | ||
| Staying in FMD | 4219 | 48.57 |
| Progressing to MMD | 3235 | 37.24 |
| Progressing to MetS | 229 | 2.64 |
| Occurrence of CVD | 953 | 10.97 |
| CVD death | 4 | 0.05 |
| OCD | 46 | 0.53 |
| From MMD | ||
| Regressing to FMD | 1521 | 12.15 |
| Staying in MMD | 6252 | 49.94 |
| Progressing to MetS | 2148 | 17.16 |
| Occurrence of CVD | 2448 | 19.55 |
| CVD death | 14 | 0.11 |
| OCD | 137 | 1.09 |
| From MetS | ||
| Staying in MetS | 3338 | 69.17 |
| Occurrence of CVD | 1414 | 29.30 |
| CVD death | 9 | 0.19 |
| OCD | 65 | 1.35 |
| From CVD cases | ||
| Censoring from CVD death or OCD death | 4666 | 97.45 |
| CVD death | 33 | 0.69 |
| OCD | 89 | 1.86 |